Immunic, Inc.

good morning and welcome to munich's first quarter 2022 earnings call my name is jessica brew head of investor relations and communications at the munich i will also be the moderator on today's call speaking on the on the call are dr daniel fit our chief executive officer and president as well as glenn whaley our recently promoted chief financial officer please note all participants will be in listen only mode and this event is being recorded After today's presentation, there will be an opportunity to ask questions. If you joined the webcast via the Zoom platform, there are two ways to submit questions. You can either submit your question in writing via the Q&A tool of the Zoom portal, or if you would like to speak with us directly, please use the raise hand function in the Zoom portal to queue your question. If you joined today's webcast by phone, please press star nine to queue a question. Before we begin, I would like to remind you that this presentation may contain forward-looking statements. Such statements can be identified by words such as may, will, expect, anticipate, estimate, or words with a similar meaning. And such statements involve a number of risks and uncertainties that could cause immune-exactual results to differ materially from those discussed here. Please note that these forward-looking statements reflect Immunix's opinions only as of the date of this presentation and it undertakes no obligation to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. Please refer to Immunix's SEC filings for a more detailed description of the risk factors that may affect Immunix's results and these forward-looking statements. I would now like to turn the call over to Dr. Daniel Fitt, our CEO and president, to begin with the presentation. Daniel, please go ahead.

Yeah, thank you, Jessica. I would like to welcome everybody to Immunix's first quarter 2022 earnings call. Earlier this morning, we announced our financial results for the quarter ended March 31st, 2022, and highlighted recent activity development pipeline. During today's call, we will talk through our first quarter 2022 and subsequent highlights, financial and operating results, as well as anticipated milestones. As Jessica noted, before we close the call, you will have the opportunity to ask questions.

The first quarter of 2022 was marked by continued 1-0-1-0-1-0-1-0-1-0-1-0-1-0-1-0-1-0-1-0-1-0-1-0-1-0-1-0-1-0-1-0-1-0-1-0-1-0-1-0-1-0-1-0-1-0-1-0-1-0